Erlotinib Completed Phase 2 Trials for Squamous Cell Carcinoma (SCC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00476476Erlotinib in Women With Squamous Cell Carcinoma of the Vulvar